936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at Memorial Sloan Kettering Cancer Center
    Journal Article

    Horvat, T. Z.; Adel, N. G.; Dang, T. O.; Momtaz, P.; Postow, M. A.; Callahan, M. K.; Carvajal, R. D.; Dickson, M. A.; D'Angelo, S. P.; Woo, K. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Evaluation of the safety and benefit of phase I oncology trials for patients with primary CNS tumors
    Journal Article

    Gounder, M. M.; Nayak, L.; Sahebjam, S.; Muzikansky, A.; Sanchez, A. J.; Desideri, S.; Ye, X.; Ivy, S. P.; Nabors, L. B.; Prados, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas
    Journal Article

    Gounder, M.; Desai, V.; Kuk, D.; Agaram, N.; Arcila, M.; Durham, B.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Shukla, N.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • TP53 mutations emerge in circulating cell-free DNA obtained from patients undergoing treatment with the HDM2 antagonist SAR405838
    Meeting Abstract

    Watters, J. W.; Dickson, M. A.; Schwartz, G. K.; Le Cesne, A.; Bahleda, R.; Wagner, A. J.; Choy, E.; De Jonge, M. J.; Light, M.; Jung, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A randomized phase Ib/II study evaluating the safety and efficacy of olaratumab (IMC-3G3), a human anti-platelet-derived growth factor alpha (PDGFR alpha) monoclonal antibody, with or without doxorubicin (Dox), in advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Tap, W. D.; Jones, R. L.; Chmielowski, B.; Elias, A. D.; Adkins, D.; Van Tine, B. A.; Agulnik, M.; Cooney, M. M.; Livingston, M. B.; Pennock, G. K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Genetically engineered NY-ESO-1 specific T cells in HLA-A201+ patients with advanced cancers
    Meeting Abstract

    Merchant, M. S.; Cristea, M. C.; Stadtmauer, E. A.; Tap, W. D.; D'Angelo, S. P.; Grupp, S. A.; Holdich, T.; Binder-Scholl, G.; Jakobsen, B. K.; Odunsi, K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab (MSB0010718C) in patients with metastatic Merkel cell carcinoma
    Meeting Abstract

    Kaufman, H.; Hamid, O.; D'Angelo, S. P.; Yuan, G. J.; Chin, K. M.; Bhatia, S.; Cuillerot, J. M.; Nghiem, P.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis
    Meeting Abstract

    Gounder, M. M.; Zer, A.; Tap, W. D.; Gupta, A. A.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Tanner, L. R.; Konen, T.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of RG7155, a novel anti-CSF1R antibody, in patients with advanced/metastatic solid tumors
    Meeting Abstract

    Gomez-Roca, C. A.; Cassier, P. A.; Italiano, A.; Cannarile, M.; Ries, C.; Brillouet, A.; Mueller, C.; Jegg, A. M.; Meneses-Lorente, G.; Baehner, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save